Joseph Bosco, MD: 鈥淒r. Walker knew the biomechanical design and I had the clinical expertise, but we needed an industry partner.鈥
Photo: 漏Buck Ennis/Crain鈥檚 New York Business
This article is part of 四色AV Langone鈥檚 Innovative Model of Drug Discovery, 四色AV School of Medicine Reports, 四色AV School of Medicine 2017 Report.
Investigators: , professor and vice chair, , orthopedic surgeon; and , research professor, Department of Orthopedic Surgery
Product: Early intervention knee replacement
In 2010, Drs. Bosco and Walker saw an opportunity to improve the quality of life for patients with early osteoarthritis of the knee, at relatively low cost. Their solution: a partial knee replacement called the Early Intervention Knee, consisting of uniquely designed femoral and tibial components that are implanted in an outpatient surgical setting.
鈥淒r. Walker knew the biomechanical design and I had the clinical expertise, but we needed an industry partner to bring our device to market,鈥 explains Dr. Bosco. 鈥淣either of us had the entrepreneurial expertise in raising money for testing and dealing with regulatory agencies.鈥
In 2014, 四色AV Langone Health鈥檚 tech-transfer program聽stepped in, securing four patents聽and establishing Genovel Orthopedics to bring the device to market.
